Anticoagulants [Pharmacological Action]
Tree Number(s): D000925
MeSH Unique ID: D000925
- acid citrate dextrose (Supplementary Concept)
- moxicoumone (Supplementary Concept)
- tocopherylquinone (Supplementary Concept)
- chlorophacinone (Supplementary Concept)
- ferulic acid (Supplementary Concept)
- protocatechualdehyde (Supplementary Concept)
- troxerutin (Supplementary Concept)
- clocoumarol (Supplementary Concept)
- calcium heparin (Supplementary Concept)
- citrate phosphate dextrose (Supplementary Concept)
- fucoidan (Supplementary Concept)
- glucuronyl glucosamine glycan sulfate (Supplementary Concept)
- laminaran (Supplementary Concept)
- antivitamins K (Supplementary Concept)
- difenacoum (Supplementary Concept)
- bromfenacoum (Supplementary Concept)
- plumbagin (Supplementary Concept)
- fluindione (Supplementary Concept)
- bromadiolone (Supplementary Concept)
- tanshinone (Supplementary Concept)
- fibrinogen fragment X (Supplementary Concept)
- nafamostat (Supplementary Concept)
- CPDA solutions (Supplementary Concept)
- danaparoid (Supplementary Concept)
- N(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide (Supplementary Concept)
- lipoprotein-associated coagulation inhibitor (Supplementary Concept)
- antistasin (Supplementary Concept)
- desirudin (Supplementary Concept)
- efegatran (Supplementary Concept)
- PENTA (Supplementary Concept)
- aprosulate (Supplementary Concept)
- parnaparin (Supplementary Concept)
- lamifiban (Supplementary Concept)
- (2S)-2-(4-(((3S)-1-acetimidoyl-3-pyrrolidinyl)oxy)phenyl)-3-(7-amidino-2-naphtyl)propanoic acid (Supplementary Concept)
- nitrophorin (Supplementary Concept)
- ardeparin (Supplementary Concept)
- reviparin (Supplementary Concept)
- certoparin (Supplementary Concept)
- bemiparin (Supplementary Concept)
- coumachlor (Supplementary Concept)
- idrabiotaparinux (Supplementary Concept)
- enoxaparin sodium (Supplementary Concept)
- glenzocimab (Supplementary Concept)
- Acenocoumarol (MeSH Term)
- Ancrod (MeSH Term)
- Dicumarol (MeSH Term)
- Dermatan Sulfate (MeSH Term)
- Dextrans (MeSH Term)
- Edetic Acid (MeSH Term)
- Ethyl Biscoumacetate (MeSH Term)
- Fibrin Fibrinogen Degradation Products (MeSH Term)
- Heparin (MeSH Term)
- Heparin, Low-Molecular-Weight (MeSH Term)
- Heparinoids (MeSH Term)
- Pentosan Sulfuric Polyester (MeSH Term)
- Phenindione (MeSH Term)
- Phenprocoumon (MeSH Term)
- Protein C (MeSH Term)
- Warfarin (MeSH Term)
- 4-Hydroxycoumarins (MeSH Term)
- Gabexate (MeSH Term)
- Protein S (MeSH Term)
- Nadroparin (MeSH Term)
- Enoxaparin (MeSH Term)
- Dalteparin (MeSH Term)
- Citric Acid (MeSH Term)
- Blood Coagulation Factor Inhibitors (MeSH Term)
- beta 2-Glycoprotein I (MeSH Term)
- Becaplermin (MeSH Term)
- Abciximab (MeSH Term)
- Sodium Citrate (MeSH Term)
- Tinzaparin (MeSH Term)
- bivalirudin (Supplementary Concept)
- melagatran (Supplementary Concept)
- argatroban (Supplementary Concept)
- lepirudin (Supplementary Concept)
- SDZ MTH 958 (Supplementary Concept)
- inogatran (Supplementary Concept)
- ximelagatran (Supplementary Concept)
- 6-methyl-1,2,3,5-tetrahydroimidazo(2,1-b)quinazolin-2-one hydrochloride (Supplementary Concept)
- HY023016 (Supplementary Concept)
- pyragrel (Supplementary Concept)
- tick anticoagulant peptide (Supplementary Concept)
- ITF 1331 (Supplementary Concept)
- SEL 2711 (Supplementary Concept)
- YM 60828 (Supplementary Concept)
- FX 2212 (Supplementary Concept)
- PD0313052 (Supplementary Concept)
- WX-FX4 compound (Supplementary Concept)
- 6-chloromethyl-3-(2,5-dichlorophenoxycarbonyl)-2-benzopyrone (Supplementary Concept)
- 3,3'-(3,5-difluoro-4-methyl-2,6-pyridinediylbis(oxy))bis(benzenecarbox(imide)amide) (Supplementary Concept)
- SF 324 (Supplementary Concept)
- RPR 130737 (Supplementary Concept)
- BnSO(2)-D-Arg-Gly-Arg-ketothiazole (Supplementary Concept)
- lefaxin (Supplementary Concept)
- N(2)-(4-(dimethylamino)benzoyl)-4-hydroxy-N(1)-(4-methoxybenzoyl)-1,2-benzenediamine (Supplementary Concept)
- 2-(4-(dimethylamino)benzoylamino)-5-methanesulfonylamino-N'-(4-methoxyphenyl)benzamide (Supplementary Concept)
- RPR 208566 (Supplementary Concept)
- N-(4-chlorophenyl)-N-(2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidiine-1,2-dicarboxamide (Supplementary Concept)
- 3-chloro-N-(4-chloro-2-(((5-chloro-2-pyridinyl)amino)carbonyl)-6-methoxyphenyl)-4-((methylamino)methyl)-2-thiophenecarboxamide (Supplementary Concept)
- 3-chloro-N-(4-chloro-2-(((5-chloro-2-pyridinyl)amino)carbonyl)-6-methoxyphenyl)-4-(((4,5-dihydro-2-oxazolyl)methylamino)methyl)-2-thiophenecarboxamide (Supplementary Concept)
- 2-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)propanoyl)piperidin-4-yl)-5-methyl-1,2-dihydro-3H-imidazo(1,5-c)imidazol-3-one (Supplementary Concept)
- 2-(5-chlorothien-2-yl)-N-(1-(1-methyl-2-(morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethenesulfonamide (Supplementary Concept)
- ZK 806299 (Supplementary Concept)
- DPC 602 (Supplementary Concept)
- RPR 209685 (Supplementary Concept)
- 1-(1-amino-7-isoquinolyl)-N-(2'-(aminosulfonyl)-1,1'-biphenyl-4-yl)-3-methyl-1H-pyrazole-5-carboxamide (Supplementary Concept)
- idraparinux (Supplementary Concept)
- edoxaban (Supplementary Concept)
- 1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1H)-one (Supplementary Concept)
- Amblyomin-X protein, Amblyomma cajennense (Supplementary Concept)
- darexaban (Supplementary Concept)
- factor Xa, Glu-Gly-Arg- (Supplementary Concept)
- 1-(2,2-difluoroethyl)pyrrolidine-3,4-dicarboxylic acid 3-((5-chloropyridin-2-yl)amide) 4-((2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl)amide) (Supplementary Concept)
- SV-66 protein, Simulium vittatum (Supplementary Concept)
- lufaxin protein, Lutzomyia longipalpis (Supplementary Concept)
- therostasin protein, Theromyzon tessulatum (Supplementary Concept)
- 3-(4-(5-(2,6-dimethyltetrahydro-1(2H)-pyridinyl)pentyl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl)-1-benzenecarboximidamide (Supplementary Concept)
- SE 170 (Supplementary Concept)
- 1-(3-(aminomethyl)phenyl)-N-(3-fluoro-2'-(methylsulfonyl)(1,1'-biphenyl)-4-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (Supplementary Concept)
- otamixaban (Supplementary Concept)
- alpha-(3-amidinylphenoxy)-2-bromo-N-(5-(pyrrolidin-1-ylcarbonyl)phenyl)phenylacetamide (Supplementary Concept)
- 4-((2-amidino-1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl)-1-(4-pyridinyl)piperidine-4-carboxylic acid monomethanesulfonate trihydrate (Supplementary Concept)
- eisenstasin (Supplementary Concept)
- N-(4-(1-(acetimidoyl)piperidin-4-yloxy)-3-carbamoylphenyl)-N-(3-(3-amidinophenyl)-2-fluoro-2-propenyl)sulfamoylacetic acid (Supplementary Concept)
- 1-(3-aminobenzisoxazol-5'-yl)-3-trifluoromethyl-6-(2'-(3-hydroxy-N-pyrrolidinyl)methyl-(1,1')-biphen-4-yl)-1,4,5,6-tetrahydropyrazolo-(3,4-c)-pyridin-7-one (Supplementary Concept)
- RWJ 445167 (Supplementary Concept)
- apixaban (Supplementary Concept)
- betrixaban (Supplementary Concept)
- BMS 269223 (Supplementary Concept)
- 6-(dimethylcarbamoyl)nicotinoyl guanidine (Supplementary Concept)
- 3-(4-(5-(2,6-dimethylpiperidin-1-yl)pentyl)-3-oxo-3,4-dihydroxyquinoxalin-2-yl)benzamidine (Supplementary Concept)
- 2-carbamoyl-4-((6-chloronaphthalen-2-yl)sulfonyl)-1-((5-methyl-4,5,6,7-tetrahydrothiazolo(5,4-c)pyridin-2-yl)carbonyl)piperazine (Supplementary Concept)
- ZK 805412 (Supplementary Concept)
- RPR 120844 (Supplementary Concept)
- isoleucyl-glutamyl-glycyl-arginine chloromethyl ketone (Supplementary Concept)
- 5-chlorothiophene-2-carboxylic acid (2-(2-methyl-3-(2-oxopyrrolidin-1-yl)benzenesulfonylamino)-3-(4-methylpiperazin-1-yl)-3-oxopropyl)amide (Supplementary Concept)
- Heparin Cofactor II (MeSH Term)
- Dabigatran (MeSH Term)
- Antithrombin III (MeSH Term)
- Hirudins (MeSH Term)
- Antithrombin Proteins (MeSH Term)
- Rivaroxaban (MeSH Term)
- Fondaparinux (MeSH Term)